Valerio Therapeutics S.A.

Valerio Therapeutics S.A.verified

ALVIO.PA

Price:

$0.164

Market Cap:

$57.34M

Valerio Therapeutics Société anonyme, a clinical-stage biotechnology company, designs and develops oncology drugs for tumor DNA repair functions worldwide. The company offers Beleodaq for the treatment of peripheral T-cell lymphoma. It also develops AsiDNA, which is in Phase 1 clinical trial for the treatment of metastatic melanoma; OX401, which is in preclinical stage for treating DNA damage response and immuno-oncology; and platON, a decoy oligonucleotide platform. It has a license agreement with Acrotech Biopharma LLC; and clinical research agreement with Gustave Roussy to conduct clinical trial of AsiDNA for the treatment of relapsed ovarian cancer. The company was formerly known as Onxe...[Read more]

Industry

Biotechnology

IPO Date

2023-06-05

Stock Exchange

PAR

Ticker

ALVIO.PA

The PE Ratio as of December 2025 (TTM) for Valerio Therapeutics S.A. (ALVIO.PA) is -1.82

According to Valerio Therapeutics S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -1.82. This represents a change of 269.16% compared to the average of -0.49 of the last 4 quarters.

Valerio Therapeutics S.A. (ALVIO.PA) Historical PE Ratio (quarterly & annually)

How has ALVIO.PA PE Ratio performed in the past?

The mean historical PE Ratio of Valerio Therapeutics S.A. over the last ten years is 0.77. The current -1.82 PE Ratio has changed -23771.59% with respect to the historical average. Over the past ten years (40 quarters), ALVIO.PA's PE Ratio was at its highest in in the June 2020 quarter at 1.05. The PE Ratio was at its lowest in in the December 2021 quarter at -5.30.

Quarterly (TTM)
Annual

Average

0.77

Median

-0.57

Minimum

-4.01

Maximum

18.14

Valerio Therapeutics S.A. (ALVIO.PA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Valerio Therapeutics S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 561.42%

Maximum Annual PE Ratio = 18.14

Minimum Annual Increase = -3791.34%

Minimum Annual PE Ratio = -4.01

Quarterly (TTM)
Annual
YearPE RatioChange
2024-0.48-56.16%
2023-1.10-24.63%
2022-1.46-63.62%
2021-4.01-122.12%
202018.14-3791.34%
2019-0.49-68.10%
2018-1.54561.42%
2017-0.23-58.68%
2016-0.56-0.64%
2015-0.57-60.37%

Valerio Therapeutics S.A. (ALVIO.PA) Average PE Ratio

How has ALVIO.PA PE Ratio performed in the past?

The current PE Ratio of Valerio Therapeutics S.A. (ALVIO.PA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-1.01

5-year avg

2.22

10-year avg

0.77

Valerio Therapeutics S.A. (ALVIO.PA) PE Ratio vs. Peers

How is ALVIO.PA’s PE Ratio compared to its peers?

Valerio Therapeutics S.A.’s PE Ratio is less than Nicox S.A. (-0.68), less than Novacyt S.A. (-0.67), less than GenSight Biologics S.A. (-0.80), greater than Advicenne S.A. (-3.64), greater than Implanet S.A. (-4.84), less than genOway S.A. (19.81), less than Poxel S.A. (-0.26), greater than Theraclion S.A. (-4.91), greater than Diagnostic Medical Systems S.A. (-14.51), less than Valbiotis S.A. (-1.11),

Build a custom stock screener for Valerio Therapeutics S.A. (ALVIO.PA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Valerio Therapeutics S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Valerio Therapeutics S.A. (ALVIO.PA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Valerio Therapeutics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Valerio Therapeutics S.A.'s PE Ratio?

How is the PE Ratio calculated for Valerio Therapeutics S.A. (ALVIO.PA)?

What is the highest PE Ratio for Valerio Therapeutics S.A. (ALVIO.PA)?

What is the 3-year average PE Ratio for Valerio Therapeutics S.A. (ALVIO.PA)?

What is the 5-year average PE Ratio for Valerio Therapeutics S.A. (ALVIO.PA)?

How does the current PE Ratio for Valerio Therapeutics S.A. (ALVIO.PA) compare to its historical average?